Patent · US Active

Anti-LGR5 antibodies and uses thereof

US10316084B2 · kind B2 · utility

0Cited by
2References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2016
Grant dateJun 11, 2019
Priority date—
Expiry dateNov 29, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-LgR5 antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.